CVS Health upgraded at TD Cowen after insurer unveils 2025 Medicare Advantage plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
Go back to CVS Health upgraded at TD Cowen after insurer unveils 2025 Medicare Advantage plan
October 8, 2024 5:50 AM EDT
Bernstein SocGen Group analyst Lance Wilkes upgraded Humana (NYSE: HUM) from Market Perform to Outperform with a price target of $308.00 (from $405.00).
The analyst comments "We are updating our model, decreasing our target price, but upgrading our rating to Outperform based on a view that risks are being incorporated into expectations and price, coupled with improving sector outlook and potential upside catalysts. Upgrading HUM, our investment thesis - We believe HUM is now an attractive... More
October 7, 2024 5:29 AM EDT
TD Cowen analyst Gary Taylor downgraded Humana (NYSE: HUM) from Buy to Hold with a price target of $261.00 (from $402.00).
The analyst comments "We are downgrading Humana from a Buy to Hold rating. Despite MA plans' ability to reprice the business each year (and... More
